411
Views
0
CrossRef citations to date
0
Altmetric
This article refers to:
Efficacy and safety of tabalumab plus standard of care in Japanese patients with active systemic lupus erythematosus: Subgroup analyses of the ILLUMINATE-1 study

Tanaka Y, Takeuchi T, Akashi N, Takita Y, Kovacs B, Kariyasu S. Efficacy and safety of tabalumab plus standard of care in Japanese patients with active systemic lupus erythematosus: Subgroup analyses of the ILLUMINATE-1 study. MOD RHEUMATOL. 2016 [ePub ahead of Print]

http://dx.doi.org/10.1080/14397595.2016.1206260

When the above article was first published online, Tsutomu Takeuchi’s affiliation was listed in error as Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Kobe, Tokyo, Japan. This has now been corrected in both the print and online versions to Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.

Taylor & Francis apologises for this error.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.